granisetron oral / Generic mfg.  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
granisetron oral / Generic mfg.
NCT01500226 / 2010-022746-24: Ph 3 Safety/Efficacy Study of Rolapitant for Prevention of CINV in Subjects Receiving Moderately Emetogenic Chemotherapy

Checkmark ASCO 2015
May 2015 - May 2015: ASCO 2015
Completed
3
1369
US
Rolapitant, Varubi, Granisetron, Kytril, Granisol, Dexamethasone, Decadron, Placebo, Placebo to match Rolapitant
Tesaro, Inc.
Chemotherapy-induced Nausea and Vomiting
02/14
02/14
NCT01500213 / 2010-022743-37: Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic Chemotherapy

Completed
3
555
US
Rolapitant, Varubi, Granisetron, Kytril, Granisol, Dexamethasone, Decadron, Placebo, Placebo to match Rolapitant
Tesaro, Inc.
Chemotherapy-induced Nausea and Vomiting
03/14
03/14
NCT01499849 / 2010-022742-25: Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic Chemotherapy

Completed
3
532
US
Rolapitant, Varubi, Granisetron, Kytril, Granisol, dexamethasone, Decadron, Placebo, Placebo to match Rolapitant
Tesaro, Inc.
Chemotherapy-induced Nausea and Vomiting
05/14
05/14

Download Options